L3VLUP
ProSign in

NTLA in the 13F filings

Intellia Therapeutics Inc · CUSIP 45826J105

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2025
the date the book describes
Filed
17 Feb 2026
latest of these filings; the earliest 12 Nov 2025
Managers listing it
7
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q2 2025 and Q3 2025; 4 listed it in both
Shares listed
19,271,811
combined, among listed positions
Reported value
$333m
combined, at the quarter end

Among the 95 comparable managers: 5 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing NTLA in Q3 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

7 of 7 holders

ActionFiling
ARK Investment Management LLC11,919,178$206m1.23%Trimmed-1,098,69812 Nov 2025 (the filing on sec.gov)
Two Sigma Investments LP2,449,607$42m0.06%Addedn.a.14 Nov 2025 (the filing on sec.gov)
Two Sigma Advisers LP2,163,417$37m0.07%Added+70,40014 Nov 2025 (the filing on sec.gov)
Voloridge Investment Management LLC1,610,205$28m0.09%Added+56,97114 Nov 2025 (the filing on sec.gov)
Farallon Capital Management LLC607,200$10munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Steadfast Capital Management LP365,400$6.3m0.11%Newnew14 Nov 2025 (the filing on sec.gov)
PDT Partners LLC156,804$2.7m0.17%Trimmed-39,74617 Nov 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2025 to Q3 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
5 in Q3 2024 to 6 in Q2 2026

Tracked managers listing it, at least.

0510152017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
NTLA by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20161$223kn.a.n.a.
Q4 20161$348kn.a.n.a.
Q1 20171$1.1mn.a.n.a.
Q2 20171$2.8mn.a.n.a.
Q3 20171$9.3mn.a.n.a.
Q4 20172$48mn.a.n.a.
Q1 20183$92mn.a.n.a.
Q2 20183$149mn.a.n.a.
Q3 20183$183mn.a.n.a.
Q4 20182$94mn.a.n.a.
Q1 20191$136mn.a.n.a.
Q2 20192$136mn.a.n.a.
Q3 20192$114mn.a.n.a.
Q4 20192$129mn.a.n.a.
Q1 20202$126mn.a.n.a.
Q2 20203$260mn.a.n.a.
Q3 20203$241mn.a.n.a.
Q4 20209$709mn.a.n.a.
Q1 202110$1.1bnn.a.n.a.
Q2 202111$2.6bnn.a.n.a.
Q3 202113$2.2bnn.a.n.a.
Q4 202111$2.1bnn.a.n.a.
Q1 20228$1.0bnn.a.n.a.
Q2 20227$721mn.a.n.a.
Q3 20227$892mn.a.n.a.
Q4 20227$476mn.a.n.a.
Q1 20237$575mn.a.n.a.
Q2 20236$538mn.a.n.a.
Q3 20234$366mn.a.n.a.
Q4 20236$446m60
Q1 20247$412m51
Q2 20246$332m51
Q3 20245$310m51
Q4 20247$220m70
Q1 20253$110m21
Q2 20255$170m41
Q3 20257$333m52
Q4 20255$166m2111
Q1 20265$342m1814
Q2 20266$537m2210

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

NTLA and LLY →NTLA and JNJ →NTLA and VRTX →Choose a stock to compare with NTLA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own NTLA, latest filings →Back to the 13F Explorer →